DarioHealth Corp. Cash and Restricted Cash
DarioHealth Corp. (DRIO) had Cash and Restricted Cash of $6.63 million as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-11
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $6.63M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $14.98M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $21.80M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $31.91M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2026-06-30 | $6.63M 10-Q · filed 2026-08-11 |
| 2026-03-31 | $14.98M 10-Q · filed 2026-05-13 |
| 2025-12-31 | $21.80M 10-Q · filed 2026-08-11 |
| 2025-09-30 | $31.91M 10-Q · filed 2025-11-13 |
| 2025-06-30 | $21.95M 10-Q · filed 2026-08-11 |
| 2025-03-31 | $27.85M 10-Q · filed 2026-05-13 |
| 2024-12-31 | $27.76M 10-Q · filed 2026-08-11 |
| 2024-09-30 | $16.21M 10-Q · filed 2025-11-13 |
| 2024-06-30 | $23.60M 10-Q · filed 2025-08-12 |
| 2024-03-31 | $35.04M 10-Q · filed 2025-05-14 |
| 2023-12-31 | $36.80M 10-K · filed 2026-03-19 |
| 2023-09-30 | $44.22M 10-Q · filed 2024-11-07 |
| 2023-06-30 | $52.94M 10-Q · filed 2024-08-08 |
| 2023-03-31 | $38.96M 10-Q · filed 2024-05-15 |
| 2022-12-31 | $49.47M 10-K · filed 2025-03-10 |
| 2022-09-30 | $57.20M 10-Q · filed 2023-11-02 |
| 2022-06-30 | $68.07M 10-Q · filed 2023-08-10 |
| 2022-03-31 | $55.70M 10-Q · filed 2023-05-11 |
| 2021-12-31 | $35.95M 10-K · filed 2024-03-28 |
| 2021-09-30 | $51.53M 10-Q · filed 2022-11-14 |
| 2021-06-30 | $64.06M 10-Q · filed 2022-08-15 |
| 2021-03-31 | $81.36M 10-Q · filed 2022-05-12 |
| 2020-12-31 | $28.73M 10-K · filed 2023-03-09 |
| 2020-09-30 | $37.03M 10-Q · filed 2021-11-15 |
| 2020-06-30 | $13.31M 10-Q · filed 2021-08-16 |
| 2020-03-31 | $15.96M 10-Q · filed 2021-05-17 |
| 2019-12-31 | $20.54M 10-K · filed 2022-03-22 |
| 2019-09-30 | $4.72M 10-Q · filed 2020-11-12 |
| 2019-06-30 | $8.12M 10-Q · filed 2020-08-12 |
| 2019-03-31 | $7.09M 10-Q · filed 2020-05-12 |
| 2018-12-31 | $11.13M 10-K · filed 2021-03-09 |
| 2017-12-31 | $3.92M 10-K · filed 2020-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |